Search

Ronghua Li

from San Diego, CA
Age ~51
Get Report
Also known as:
Rong Hua Li, Li Ronghua
Related to:
Fan Li, 49Jie Wen, 56Liang Liu, 63Li Pu, 50Chen Lin Li, 74Chien S Lin, 75Pohsiu Lin, 49Zhiyi Liu, 48Yungta Li, 49
Connected to:
Aici Li, 51Anbei L Li, 70Arden Y Li, 42Baiyong Li, 55Biao Li, 56Binglin Li, 43Candace H Li, 30Changhong Li, 56Chenglong Li, 59Chine E Li, 55

Ronghua Li Phones & Addresses

  • San Diego, CA
  • 12188 N New Dawn Ave, Tucson, AZ 85755
  • Oro Valley, AZ
  • Bridgewater, NJ
  • Davis, CA
  • Berkeley, CA
  • 907 W Morning Thunder Ct, Oro Valley, AZ 85755

Resumes

Resumes

Ronghua Li Photo 1

Scientist

View page
Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Plexium
Scientist
Icagen
Scientist Ii
Sanofi Jan 1, 2013 - Jun 2016
Scientist Ii
Sanofi Apr 2006 - Dec 2012
Scientist I
Johnson & Johnson Jul 2003 - Feb 2006
Associate Scientist
Education:
University of California, Davis 2000 - 2003
Master of Science, Masters, Organic Chemistry Nankai University 1988 - 1992
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Discovery
Medicinal Chemistry
Organic Synthesis
Drug Design
Pharmaceutical Industry
Drug Development
Organic Chemistry
Chromatography
Hplc
Lead Change
Chemistry
Lc Ms
Parallel Synthesis
Purification
Glp
Nmr
Solid Phase Synthesis
Ronghua Li Photo 2

Ronghua Li

View page
Ronghua Li Photo 3

Ronghua Li

View page
Ronghua Li Photo 4

Ronghua Li

View page

Publications

Us Patents

Substituted Pyrimidine Kinase Inhibitors

View page
US Patent:
8013153, Sep 6, 2011
Filed:
Mar 23, 2007
Appl. No.:
11/690305
Inventors:
Jeannene Butler - Washington NJ, US
Peter J. Connolly - New Providence NJ, US
Angel R. Fuentes-Pesquera - New Brunswick NJ, US
Lee M. Greenberger - Montclair NJ, US
Shenlin Huang - San Diego CA, US
Ronghua Li - Bridgewater NJ, US
Guozhang Xu - Bensalem PA, US
Assignee:
Janssen Pharmaceutica, N.V. - Beerse
International Classification:
C07D 403/12
C07D 403/14
A61K 31/506
A61P 19/02
US Classification:
544298, 514269, 544321, 544320, 544319
Abstract:
The present invention is directed to substituted pyrimidine compounds of formula (I):.

Azacarboline Derivatives, Preparation Method Thereof And Therapeutic Use Of Same

View page
US Patent:
20110178053, Jul 21, 2011
Filed:
Jun 11, 2009
Appl. No.:
12/997326
Inventors:
Christopher Arendt - Bridgewater NJ, US
Didier Babin - Paris, FR
Olivier Bedel - Paris, FR
Thierry Gouyon - Paris, FR
Mikhail Levit - Bridgewater NJ, US
Ronghua Li - Bridgewater NJ, US
Serge Mignani - Paris, FR
Neil Moorcroft - Bridgewater NJ, US
David Papin - Paris, FR
Assignee:
SANOFI-AVENTIS - Paris
International Classification:
A61K 31/555
C07D 403/14
A61K 31/496
C07D 471/14
A61K 31/4375
C07D 413/14
A61K 31/5377
C07D 401/14
A61K 31/551
A61K 31/506
C07F 9/92
A61P 35/00
US Classification:
514189, 544361, 51425303, 546 82, 514293, 544126, 5142328, 540575, 514218, 544316, 514274, 546 4
Abstract:
The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H; hal; CF; substituted oxy, optionally substituted alkoxy; optionally substituted amino; substituted carbonyl; optionally substituted carboxyl; optionally substituted amide; sulphur, such as optionally substituted sulphones, sulphoxides or sulphides; linear, branched or cyclic C-Calkyl optionally comprising an optionally substituted heteroatom; optionally substituted linear, branched or cyclic C-Calkenyl; optionally substituted linear or branched C-Calkynyl; optionally substituted aryl or heteroaryl; of which may be optionally substituted; in the form of a base or an acid addition salt. The invention also relates to the use of same in therapeutics for the treatment of cancer and to synthesis methods.

Pyrimidinyl Substituted Fused-Pyrrolyl Compounds Useful In Treating Kinase Disorders

View page
US Patent:
7855205, Dec 21, 2010
Filed:
Oct 28, 2005
Appl. No.:
11/260986
Inventors:
Shenlin Huang - Raritan NJ, US
Ronghua Li - Bridgewater NJ, US
Peter J. Connolly - New Providence NJ, US
Stuart L. Emanuel - Doylestown PA, US
Steven A. Middleton - Flemington NJ, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 403/04
A61K 31/407
US Classification:
5142358, 51425304, 514275, 544122, 544295, 544331
Abstract:
The present invention provides pyrimidinyl substituted fused-pyrrolyl compounds of Formula (I).

Pikfyve Kinase Inhibitors

View page
US Patent:
20200199136, Jun 25, 2020
Filed:
Aug 28, 2018
Appl. No.:
16/641159
Inventors:
- Monrovia CA, US
Ronghua Li - Oro Valley AZ, US
Anil Nair - Oro Valley AZ, US
Paul August - Oro Valley AZ, US
Kirsten Bjergarde - Oro Valley AZ, US
International Classification:
C07D 491/048
C07D 413/14
C07D 405/14
Abstract:
The present invention relates to compounds of formula (I) (shown below) useful as inhibitors of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) as well as their use for treating diseases and disorders associated with PIKfyve.

Wikipedia

Li Rghua

View page

Li Ronghua is a female Chinese rower. She competed at 1988 Seoul Olympic Games. Together with her teammates, she won a silver medal in Women's Coxed Four, and a bronze medal ...

China at the 1988 Summer Olympics

View page

Hu Yadong, Li Ronghua, Zhang Xianghua, Zhou Shouying and Yang Xiao Rowing, Women's Coxed Fours; Bronze. Li Guojun, Zhao Hong, Hou Yuzhu, Wang Yajun, Yang Xilan, Su Huijuan, Jiang ...

Isbn (Books And Publications)

Generalized Difference Methods for Differential Equations: Numerical Analysis of Finite Volume Methods

View page
Author

Ronghua Li

ISBN #

0824703308

Control profile
Ronghua Li from San Diego, CA, age ~51 Get Report